These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 6321384

  • 1. Lyt-1+ T cells participate in recovery from ocular herpes simplex virus type 1 infection.
    Oakes JE, Rector JT, Lausch RN.
    Invest Ophthalmol Vis Sci; 1984 Feb; 25(2):188-94. PubMed ID: 6321384
    [Abstract] [Full Text] [Related]

  • 2. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA, Knipe DM.
    Virology; 1997 Dec 22; 239(2):315-26. PubMed ID: 9434723
    [Abstract] [Full Text] [Related]

  • 3. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection.
    Cheng H, Tumpey TM, Staats HF, van Rooijen N, Oakes JE, Lausch RN.
    Invest Ophthalmol Vis Sci; 2000 May 22; 41(6):1402-9. PubMed ID: 10798656
    [Abstract] [Full Text] [Related]

  • 4. Resolution of HSV corneal infection in the absence of delayed-type hypersensitivity.
    Lausch RN, Kleinschradt WR, Monteiro C, Kayes SG, Oakes JE.
    Invest Ophthalmol Vis Sci; 1985 Nov 22; 26(11):1509-15. PubMed ID: 2997073
    [Abstract] [Full Text] [Related]

  • 5. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology.
    Hendricks RL, Tumpey TM.
    Invest Ophthalmol Vis Sci; 1990 Oct 22; 31(10):1929-39. PubMed ID: 2170289
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.
    Rager-Zisman B, Allison AC.
    J Immunol; 1976 Jan 22; 116(1):35-40. PubMed ID: 173758
    [Abstract] [Full Text] [Related]

  • 7. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations.
    Ghiasi H, Cai S, Slanina S, Nesburn AB, Wechsler SL.
    Invest Ophthalmol Vis Sci; 1997 May 22; 38(6):1213-21. PubMed ID: 9152241
    [Abstract] [Full Text] [Related]

  • 8. [Effects of T cell subsets on mouse herpetic keratitis].
    Yamashiro H.
    Nippon Ganka Gakkai Zasshi; 1990 May 22; 94(5):462-8. PubMed ID: 2220489
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV, Pettey CL, Collins JJ.
    Cancer Res; 1984 Apr 22; 44(4):1489-98. PubMed ID: 6608407
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Defective production of anti-herpes simplex virus antibody by neonatal mice. Reconstitution with Ia+ macrophages and T helper lymphocytes from nonimmune adult syngeneic mice.
    Kohl S, Thomas JW, Loo LS.
    J Immunol; 1986 Apr 15; 136(8):3038-44. PubMed ID: 3007609
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. II. Adherent cell-mediated protection.
    Stohlman SA, Frelinger JA, Weiner LP.
    J Immunol; 1980 Apr 15; 124(4):1733-9. PubMed ID: 6245128
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
    Smith PM, Wolcott RM, Chervenak R, Jennings SR.
    Virology; 1994 Jul 15; 202(1):76-88. PubMed ID: 7912023
    [Abstract] [Full Text] [Related]

  • 18. A role for T lymphocytes in preventing experimental herpes simplex virus type 1-induced retinitis.
    Whittum-Hudson J, Farazdaghi M, Prendergast RA.
    Invest Ophthalmol Vis Sci; 1985 Nov 15; 26(11):1524-32. PubMed ID: 3877027
    [Abstract] [Full Text] [Related]

  • 19. Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system.
    Shimeld C, Hill TJ, Blyth WA, Easty DL.
    J Gen Virol; 1990 Mar 15; 71 ( Pt 3)():681-7. PubMed ID: 2156001
    [Abstract] [Full Text] [Related]

  • 20. Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1.
    Ikemoto K, Pollard RB, Fukumoto T, Morimatsu M, Suzuki F.
    J Immunol; 1995 Aug 01; 155(3):1326-33. PubMed ID: 7636198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.